EBV infection renders B cells resistant to growth inhibition via adenylyl cyclase

Cellular Signalling

Volumn 20, Issue 6, 2008, Pages 1169-1178

  Kloster, Martine Müller ^a   Hafte, Tilahun Tolesa ^a   Moltzau, Lise Román ^a   Naderi, Elin Hallan ^a   Dahle, Maria Krudtaa ^b   Skålhegg, Bjørn Steen ^a   Gaudernack, Gustav ^c   Levy, Finn Olav ^a   Naderi, Soheil ^a   Blomhoff, Heidi Kiil ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Center of Clinical Epidemiology   (Norway)

Author keywords

Adenylyl cyclase; B cells; cAMP; EBV; Growth resistance

Indexed keywords

ADENYLATE CYCLASE; CAMPTOTHECIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; ISOPRENALINE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL GROWTH; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; VIRUS INFECTION;

ADENYLATE CYCLASE; APOPTOSIS; B-LYMPHOCYTES; CAMPTOTHECIN; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORSKOLIN; HERPESVIRUS 4, HUMAN; HUMANS; ISOPROTERENOL; SIGNAL TRANSDUCTION;

HUMAN HERPESVIRUS 4;

EID: 42249109181     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2008.02.007     Document Type: Article

References (45)

1. Young L.S., and Rickinson A.B. Nat. Rev., Cancer 4 (2004) 757
2. Wensing B., and Farrell P.J. Microbes Infect. 2 (2000) 77
3. Kuppers R. Nat. Rev., Immunol. 3 (2003) 801
4. Thompson M.P., and Kurzrock R. Clin. Cancer Res. 10 (2004) 803
5. Blomhoff H.K., Smeland E., Mustafa A.S., Godal T., and Ohlsson R. Eur. J. Immunol. 17 (1987) 299
6. Arvanitakis L., Yaseen N., and Sharma S. J. Immunol. 155 (1995) 1047
7. O'Nions J., and Allday M.J. Oncogene 22 (2003) 7181
8. Torgersen K.M., Vang T., Abrahamsen H., Yaqub S., and Tasken K. Cell. Signal. 14 (2002) 1
9. Ledbetter J.A., Parsons M., Martin P.J., Hansen J.A., Rabinovitch P.S., and June C.H. J. Immunol. 137 (1986) 3299
10. Kvanta A., Gerwins P., Jondal M., and Fredholm B.B. Cell. Signal. 2 (1990) 461
11. Aandahl E.M., Aukrust P., Skalhegg B.S., Muller F., Froland S.S., Hansson V., and Tasken K. FASEB J. 12 (1998) 855
12. Rahmouni S., Aandahl E.M., Trebak M., Boniver J., Tasken K., and Moutschen M. FASEB J. 15 (2001) 1466
13. Skalhegg B.S., Landmark B.F., Doskeland S.O., Hansson V., Lea T., and Jahnsen T. J. Biol. Chem. 267 (1992) 15707
14. Naderi S., Gutzkow K.B., Christoffersen J., Smeland E.B., and Blomhoff H.K. Eur. J. Immunol. 30 (2000) 1757
15. Blomhoff H.K., Smeland E.B., Beiske K., Blomhoff R., Ruud E., Bjoro T., Pfeifer-Ohlsson S., Watt R., Funderud S., and Godal T. J. Cell. Physiol. 131 (1987) 426
16. Gutzkow K.B., Naderi S., and Blomhoff H.K. J. Cell Sci. 115 (2002) 1073
17. Gutzkow K.B., Lahne H.U., Naderi S., Torgersen K.M., Skalhegg B., Koketsu M., Uehara Y., and Blomhoff H.K. Cell. Signal. 15 (2003) 871
18. Naderi S., Gutzkow K.B., Lahne H.U., Lefdal S., Ryves W.J., Harwood A.J., and Blomhoff H.K. J. Cell Sci. 117 (2004) 3769
19. Naderi S., Wang J.Y., Chen T.T., Gutzkow K.B., and Blomhoff H.K. Mol. Biol. Cell 16 (2005) 1527
20. Funderud S., Erikstein B., Asheim H.C., Nustad K., Stokke T., Blomhoff H.K., Holte H., and Smeland E.B. Eur. J. Immunol. 20 (1990) 201
21. Klein G., Sugden B., Leibold W., and Menezes J. Intervirology 3 (1974) 232
22. Engedal N., Gjevik T., Blomhoff R., and Blomhoff H.K. J. Immunol. 177 (2006) 2851
23. Kvissel A.K., Orstavik S., Oistad P., Rootwelt T., Jahnsen T., and Skalhegg B.S. Cell. Signal. 16 (2004) 577
24. Krobert K.A., Bach T., Syversveen T., Kvingedal A.M., and Levy F.O. Arch. Pharmacol. 363 (2001) 620
25. Risoe P.K., Wang Y., Stuestol J.F., Aasen A.O., Wang J.E., and Dahle M.K. Biochim. Biophys. Acta 1772 (2007) 32
26. Darzynkiewicz Z., Bruno S., Del B.G., Gorczyca W., Hotz M.A., Lassota P., and Traganos F. Cytometry 13 (1992) 795
27. Ormerod M.G., Collins M.K., Rodriguez-Tarduchy G., and Robertson D. J. Immunol. Methods 153 (1992) 57
28. Sassone-Corsi P. Int. J. Biochem. Cell Biol. 30 (1998) 27
29. Seamon K.B., Padgett W., and Daly J.W. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 3363
30. Hanoune J., and Defer N. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 145
31. Hacker B.M., Tomlinson J.E., Wayman G.A., Sultana R., Chan G., and Villacres E. Genomics 50 (1998) 97
32. Skalhegg B.S., Funderud A., Henanger H.H., Hafte T.T., Larsen A.C., Kvissel A.K., Eikvar S., and Orstavik S. Curr. Drug Targets 6 (2005) 655
33. Spada A., Lania A., and Ballare E. Mol. Cell Endocrinol. 142 (1998) 1
34. Stergiopoulos S.G., and Stratakis C.A. FEBS Lett. 546 (2003) 59
35. Nilsson K. Hum. Cell 5 (1992) 25
36. Ludlow J.W. FASEB J. 7 (1993) 866
37. Mori N., Morishita M., Tsukazaki T., and Yamamoto N. Int. J. Cancer 105 (2003) 661
38. Salesse R., and Garnier J. Mol. Cell. Biochem. 60 (1984) 17
39. Schimmer B.P., Tsao J., and Borenstein R. J. Biol. Chem. 262 (1987) 15521
40. Neer E.J., and Clapham D.E. Nature 333 (1988) 129
41. Jakobs K.H., Aktories K., and Schultz G. Nature 303 (1983) 177
42. Al-Hakim A., Rui X., Tsao J., Albert P.R., and Schimmer B.P. Mol. Cell. Endocrinol. 214 (2004) 155
43. Lam N., and Sugden B. Cell. Signal. 15 (2003) 9
44. Panagopoulos D., Victoratos P., Alexiou M., Kollias G., and Mosialos G. J. Virol. 78 (2004) 13253
45. Natsukari N., Kulaga H., Baker I., Wyatt R.J., and Masserano J.M. Psychopharmacology (Berl.) 130 (1997) 235